Legal Representation
Attorney
Colleen Ganin
USPTO Deadlines
Next Deadline
497 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210601)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 28, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Feb 28, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 28, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 28, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 1, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 28, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 27, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 21, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 7, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 21, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 7, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 21, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 7, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 7, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 22, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 18, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 18, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 18, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 31, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 31, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 31, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 24, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 22, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 22, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 22, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 23, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 1, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 1, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 1, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 1, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 1, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 26, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 9, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 7, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Providing medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment
First Use Anywhere:
Dec 5, 2020
First Use in Commerce:
Dec 5, 2020
Additional Information
Design Mark
The mark consists of the words "ALLOGENE THERAPEUTICS" next to a dotted circle design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"